Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Patients With Chronic Low Back Pain
NCT06859957Phase 3Active, not recruiting
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic low back pain (CLBP) comparing Placebo with Melatonin (2 arms). Primary endpoint: Change in low back pain intensity at 6 weeks. Started Apr 2025; status: active, not recruiting.
02
Drugs
melatonin
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT06859957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06859957.